Abbott Laboratories buy Wells Fargo & Company
Start price
19.10.23
/
50%
€88.90
Target price
19.10.24
€109.69
Performance (%)
12.51%
Price
11:15
€99.00
Summary
This prediction is currently active. The prediction currently has a performance of 12.51%. Dividends of €1.02 are taken into consideration when calculating the performance. This prediction currently runs until 19.10.24. The prediction end date can be changed by Wells_Fargo___Compan at any time. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Abbott Laboratories | -2.090% | -2.090% |
| iShares Core DAX® | -0.922% | -1.078% |
| iShares Nasdaq 100 | 0.371% | -0.556% |
| iShares Nikkei 225® | 2.224% | -2.825% |
| iShares S&P 500 | -0.026% | -0.788% |
Comments by Wells_Fargo___Compan for this prediction
In the thread Discuss Abbott Laboratories
Abbott Laboratories (NYSE: ABT) had its price target lowered by analysts at Wells Fargo & Company from $136.00 to $116.00. They now have an "overweight" rating on the stock.
Ratings data for ABT provided by MarketBeat
Stopped prediction by Wells_Fargo___Compan for Abbott Laboratories
Abbott Laboratories
Start price
Target price
Perf. (%)
€93.86
05.04.23
05.04.23
€124.25
05.04.24
05.04.24
8.89%
06.04.24
06.04.24
